breast cancer

What Does a Star Fruit Taste Like?

Unripe star fruits are dark green but as they ripen Star fruit, also known as carambola or Averrhoa Starfruit, is widely distributed around the world but is more popular in tropical areas, such as India, Malaysia, Indonesia, and the Philippines. Unripe star fruits are dark green but as they ripen, they turn yellow. Ripe star-fruits …

Read More »

Lynparza (olaparib) Cancer Medication: Side Effects & Dosage

What is Lynparza, and how does it work? Lynparza is a prescription medicine used to treat adults who have: advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer with a certain type of inherited (germline) or acquired (somatic) abnormal BRCA gene. Lynparza is used alone as maintenance treatment after the cancer has responded to your first treatment with platinum-based …

Read More »

Erbitux (cetuximab) for Colorectal Cancer: Side Effects & Warnings

What is Erbitux, and how does it work? Erbitux (cetuximab), in combination with radiation therapy, is a monoclonal antibody indicated for the initial treatment of locally or regionally advanced head and neck cancer of a specific type (squamous cell carcinoma). Used alone, Erbitux is also approved to treat patients with head and neck cancers that have returned in the same …

Read More »

Motegrity (prucalopride) Constipation Medication: Side Effects & Dosage

What is Motegrity, and how does it work? Motegrity is a prescription medicine used in adults to treat a type of constipation called chronic idiopathic constipation (CIC). Idiopathic means the cause of the constipation is unknown. It is not known if Motegrity is safe and effective in children. What are the side effects of Motegrity? Motegrity may cause serious side …

Read More »

Perimenopause: Symptoms, Causes, 8 Lifestyles Changes & Treatment

Perimenopause definition and facts Readers Comments 1 Share Your Story Perimenopause is the name for menstrual symptoms leading up to menopause. Menopause is the time during a woman's lifetime when menstrual periods cease. The medical definition of menopause is the time at which a woman has not had a menstrual period for 12 consecutive months. The time preceding menopause has …

Read More »

Bavencio (avelumab) for Cancer Treatment: Interactions & Warnings

What is Bavencio, and how does it work? Bavencio is a prescription medicine used to treat: a type of skin cancer called Merkel cell carcinoma (MCC) in adults and children 12 years of age and older. Bavencio may be used when your skin cancer has spread. a type of cancer in the bladder or urinary tract called urothelial carcinoma (UC). …

Read More »

What Is Hypertrophy Training?

In hypertrophic training, people will do more sets and repetitions with lighter weights. Hypertrophy training is a type of weight training that is common among bodybuilders and athletes. The aim of this training is to build the muscles of the body. Weight training is a type of exercise regimen that uses weights for resistance, thus causing stress to the muscle, …

Read More »

What Happens If the Hypothalamus Is Damaged?

Hypothalamus is the head of all endocrine glands. It coordinates the functions of all endocrine glands in the body. The endocrine glands secrete their hormones (chemical messengers) directly into the blood. The hypothalamus controls a variety of body functions and hormones. Damage to the hypothalamus, whether at birth or acquired, will lead to significant health issues. Such as: Diabetes insipidus: …

Read More »

Libtayo (cemiplimab-rwlc) for Skin Cancer: Side Effects & Dosage

What is Libtayo, and how does it work? Libtayo is a prescription medicine used to treat people with a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread or cannot be cured by surgery or radiation. It is not known if Libtayo is safe and effective in children. What are the side effects of Libtayo? The …

Read More »

Imfinzi (durvalumab) for Cancer: Side Effects & Dosage

What is Imfinzi, and how does it work? Imfinzi (durvalumab) is a programmed death-ligand 1 (PD-L1) blocking antibody indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing chemotherapy; or who have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy. It is also used …

Read More »